{
    "cancelStatus": "1",
    "cancelDate": "2018-09-13",
    "cancelReason": [
        "841"
    ],
    "licid": "06012097",
    "validDate": "2020-08-19 00:00:00.000",
    "issueDate": "2005-08-19 00:00:00.000",
    "licKind": "09",
    "oldLicid": null,
    "certNo": "DHA00601209704",
    "prodNameC": "貝克曼庫特亞特美-D膽紅素品管液",
    "prodNameE": "BECKMAN COULTER Ultimate-D Bilirubin Controls",
    "indicationsName": [],
    "does": null,
    "packageUnit": [],
    "medMCode": null,
    "maMedCode": null,
    "medDCode": null,
    "ingredientsDesc": [
        "Ultimate-D Bilirubin Controls are prepared by the addition of a special bilirubin preparation to human serum which is stabilized by the use of ethylene glycol."
    ],
    "restraintItemsCode": [
        "R02"
    ],
    "applicantName": "美商貝克曼庫爾特有限公司台灣分公司",
    "applicantAddr": "台北市大安區敦化南路二段216號8樓",
    "medClass": "2",
    "efficacy": "亞特美-D膽紅素品管液在手工和自動分析系統中，可作為總膽紅素與直接膽紅素之品質管理。 ",
    "mdFormat": "品管液1 10×3ML REF#667710品管液2 10×3ML REF#667720品管液3 10×3ML REF#667730品管液4 10×3ML REF#667740",
    "productAnnotation": null,
    "mdKind": [
        {
            "mdKindMCode": "A",
            "mdKindMCodeName": "A 臨床化學及臨床毒理學用裝置",
            "mdKindDCode": ".",
            "mdKindDCodeName": null,
            "checkChange": "N"
        }
    ],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "BECKMAN COULTER INC.",
            "factoryAddr": "2470 FARADAY AVENUE, CARLSBAD, CA 92010, U.S.A.",
            "factoryCompanyAddr": null,
            "countryCode": "US",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "MUS3803000",
            "factoryInfo": "1",
            "qsd": "QSD4031"
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsDesc": "Ultimate-D Bilirubin Controls are prepared by the addition of a special bilirubin preparation to human serum which is stabilized by the use of ethylene glycol.",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [
        {
            "fileType": "2",
            "fileName": "060120970001.pdf",
            "fileStreamId": "447FD573-74D3-4BB9-A2E7-0E3C6E91BF0E"
        },
        {
            "fileType": "2",
            "fileName": "060120970002.pdf",
            "fileStreamId": "4FBF107A-99F8-41F5-AAAD-AE8DB6A22530"
        },
        {
            "fileType": "2",
            "fileName": "060120970003.pdf",
            "fileStreamId": "9E29E786-70FA-4AC7-886A-D5F67B787C7E"
        },
        {
            "fileType": "2",
            "fileName": "060120970004.pdf",
            "fileStreamId": "C8CB32D7-162D-49C0-A707-CF9973EC2DF4"
        },
        {
            "fileType": "2",
            "fileName": "060120970005.pdf",
            "fileStreamId": "7686BE52-C915-47F0-A2DB-74BA64220613"
        },
        {
            "fileType": "1",
            "fileName": "060120970001.pdf",
            "fileStreamId": "2CA40938-6BC4-4EFC-BC01-C91FB74222FB"
        },
        {
            "fileType": "1",
            "fileName": "060120970002.pdf",
            "fileStreamId": "1E5CBC5C-09A0-48AD-8D53-FB11A9590BF2"
        },
        {
            "fileType": "1",
            "fileName": "060120970003.pdf",
            "fileStreamId": "01E0ABD0-72DE-4C8C-86AB-326268CF08DE"
        }
    ],
    "changeDtoList": [],
    "atcList": []
}